Cian Healthcare Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 12-12-2024
- Paid Up Capital ₹ 25.00 Cr
as on 12-12-2024
- Company Age 21 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 60.50 Cr
as on 12-12-2024
- Satisfied Charges ₹ 0.25 M
as on 12-12-2024
- Revenue -11.04%
(FY 2022)
- Profit -796.60%
(FY 2022)
- Ebitda -46.00%
(FY 2022)
- Net Worth 0.79%
(FY 2022)
- Total Assets 3.83%
(FY 2022)
About Cian Healthcare
- CIN/LLPIN
L24233PN2003PLC017563
- Company No.
017563
- Stock Symbol
BSE : 542678
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
07 Jan 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Cian Healthcare Limited offer?
Cian Healthcare Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Blood Pressure Medicine, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Multivitamin Tablets & Capsules, Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Diabetes Medicine, Common Disease Medicines, Pharmaceutical Medicine.
Who are the key members and board of directors at Cian Healthcare?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suraj Zanwar  | Managing Director | 07-Jan-2003 | Current |
| Riyaz Khan | CFO | 12-Jun-2020 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Santosh Shivaji | Director | 11-Oct-2023 | Current |
| Sunil Kumar | Director | 03-Sep-2022 | Current |
Financial Performance of Cian Healthcare.
Cian Healthcare Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 11.04% decrease. The company also saw a substantial fall in profitability, with a 796.6% decrease in profit. The company's net worth moved up by a moderate rise of 0.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cian Healthcare?
In 2021, Cian Healthcare had a promoter holding of 70.89% and a public holding of 29.11%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Idbi Bank Limited Creation Date: 16 Sep 2009 | ₹60.50 Cr | Open |
Cholamandalam Investment And Finance Company Limited Creation Date: 24 Jun 2011 | ₹0.25 M | Satisfied |
How Many Employees Work at Cian Healthcare?
Cian Healthcare has a workforce of 172 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cian Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cian Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
